These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12119552)
1. Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis. Osaki M; Osaki M; Yamashita H; Shomori K; Yoshida H; Ito H Int J Mol Med; 2002 Aug; 10(2):161-8. PubMed ID: 12119552 [TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 in human malignant fibrous histiocytoma: correlations with intratumoral microvessel density, expression of vascular endothelial growth factor and thymidine phosphorylase. Yamashita H; Osaki M; Ardyanto TD; Osaki M; Yoshida H; Ito H Int J Mol Med; 2004 Oct; 14(4):565-70. PubMed ID: 15375582 [TBL] [Abstract][Full Text] [Related]
4. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445 [TBL] [Abstract][Full Text] [Related]
5. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987 [TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768 [TBL] [Abstract][Full Text] [Related]
8. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications. Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Yang P; Hirose T; Hasegawa T; Seki K; Sano T; Hizawa K Cancer; 1995 Aug; 76(4):618-25. PubMed ID: 8625155 [TBL] [Abstract][Full Text] [Related]
10. P-53 positivity and high proliferative index: factors of bad prognosis in malignant fibrous histiocytomas. Brinck U; Stachura J; Rudzki Z; Kellner S; Hoefer K; Schauer A In Vivo; 1995; 9(5):475-8. PubMed ID: 8900926 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685 [TBL] [Abstract][Full Text] [Related]
12. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]
13. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
14. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042 [TBL] [Abstract][Full Text] [Related]
15. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627 [TBL] [Abstract][Full Text] [Related]
16. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. Soini Y; Vähäkangas K; Nuorva K; Kamel D; Lane DP; Pääkkö P J Pathol; 1992 Sep; 168(1):29-33. PubMed ID: 1333524 [TBL] [Abstract][Full Text] [Related]
17. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Zhang Z; Ma J; Li N; Sun N; Wang C Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222 [TBL] [Abstract][Full Text] [Related]
18. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961 [TBL] [Abstract][Full Text] [Related]
19. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [TBL] [Abstract][Full Text] [Related]
20. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues. Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]